HR 2405
117th Congress
House
Crime and Law Enforcement
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Government studies and investigations
Licensing and registrations
Medical research
Streamlining Research on Controlled Substances Act of 2021
Introduced: April 8, 2021
Introduced by:
Griffith, H. Morgan
Republican
· Virginia
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 19, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Apr 13, 2021
Referred to the Subcommittee on Health.
Apr 8, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 8, 2021
Introduced in House
Plain-English summary
Streamlining Research on Controlled Substances Act of 2021
This bill makes changes to the registration process for conducting research on controlled substances that are included in schedule I of the Controlled Substances Act.
Among the changes, the bill does the following:
- exempts from the registration requirements an agent or employee of a registered researcher,
- permits a single registration for contiguous research sites, and
- requires the Drug Enforcement Administration and the Department of Health and Human Services to review and issue guidance on the processes to obtain or modify federal authorization to conduct research with controlled substances.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committees of jurisdiction
4
Cosponsors
1